Every one of those 1 sits in a single category, ipo. Kfin Technologies is most often covered alongside Gaudium IVF and Women Health, which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Kfin Technologies
Every one of those 1 sits in a single category, ipo. Kfin Technologies is most often covered alongside Gaudium IVF and Women Health, which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.4 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.5 for that window. Kfin Technologies appears in 1 tracked Startup story from February 24, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 32 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Kfin Technologies. Shared-story counts are live from our verified record — not editorial picks.
Gaudium IVF and Women Health's ₹125.22 crore IPO entered its final bidding day with a 3x overall subscription and a steady grey market premium. The offering, consisting entirely of a fresh issue, has seen particularly robust interest from retail investors as the company seeks to expand its fertility clinic network.